IAMH
LABU icon

IvyRock Asset Management (HK)’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

IvyRock Asset Management (HK)’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,200
Closed -$768K – 26
2025
Q3 		$768K Buy
+8,200
New +$579K 0.33% 9

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IvyRock Asset Management (HK)'s LABU Position: Q4 2025 in Review

IvyRock Asset Management (HK) sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2025, closing a stake of 8,200 shares — an estimated $768K sold.

IvyRock Asset Management (HK) first reported a position in LABU in Q3 2025 and held it in 1 quarter. The position peaked at $768K in Q3 2025. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.

  • IvyRock Asset Management (HK) reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
  • IvyRock Asset Management (HK) sold 8,200 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2025, an estimated $768K.
  • IvyRock Asset Management (HK) first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2025 and held it in 1 quarter.
  • IvyRock Asset Management (HK)'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $768K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.

Based on IvyRock Asset Management (HK)'s 13F filing for Q4 2025, filed 11 Feb 2026.